Cytek Biosciences, Inc. — Form 10-Q
Filed November 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 18/100
What the filing says
Cytek hired Philippe Busque as Regional General Manager, reporting to CEO Wenbin Jiang, effective August 24, 2026. Compensation: $369,000 annual base salary, 45% target bonus, and $400,000 equity grant (25% stock options, 75% RSUs vesting over 4 years). Standard benefits and severance plan eligibility included. This is a mid-level sales/regional operations hire.
Why this rating
Single mid-level executive hire with routine compensation. $769K total year-1 cost is ~0.2% of company's $393M market cap—immaterial to business trajectory.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.